The House today passed legislation that would suspend through 2022 tariffs on certain infant formula base powders used to make infant formula in the United States. Congress in July passed legislation (H.R.8351) suspending tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage  to help health care providers and families locate formula.
 

Related News Articles

Headline
AHA Sept. 20 urged leaders of the Senate Health, Education, Labor and Pensions Committee to remove from the Bipartisan Primary Care and Health Workforce…
Headline
Certain policy decisions and challenges in implementing the No Surprises Act have undermined the unbiased and timely process Congress intended and contributed…
Headline
The AHA and American Medical Association Sept. 18 urged the U.S. Court of Appeals for the 5th Circuit to affirm a district court decision that invalidated a No…
Headline
Sens. Joe Manchin, D-W.Va., and Marco Rubio, R-Fla., Sept. 12 introduced the Safety from Violence for Healthcare Employees Act, AHA-supported legislation that…
Headline
Republicans on the House Energy and Commerce, Ways and Means, and Education & Workforce Committees have released a summary of draft legislation the…
Headline
In a letter Aug. 1 to House and Senate sponsors, the AHA and 48 other national associations voiced strong support for the Conrad State 30 and Physician…